DELIC HOLDINGS CORP - DELCF STOCK NEWS

Delic Holdings Corp (CSE: DELC, OTCQB: DELCF) announced that Dr. Markus Roggen, President and CSO of Delic Labs, will present at the Grow Up Conference and Expo in Victoria, British Columbia from June 20-22, 2022. He will discuss advancements in psychedelics and cannabis extraction technologies. The event includes panels on psychedelics and sustainable extraction. Recently, Delic Labs received a Health Canada 56 Research Exemption to research various psychedelic compounds, enhancing their role in psychedelic safety testing and cannabis innovation.

Delic Holdings Corp has expanded its Ketamine Wellness Centers (KWC) by introducing the FDA-approved SPRAVATO® esketamine nasal spray in three new cities—Minneapolis, Salt Lake City, and Dallas—effective June 1, 2022. This brings the total to six cities offering the treatment, alongside Houston, Las Vegas, and Seattle. SPRAVATO is designed for adults with treatment-resistant depression or major depressive disorder. Many insurers cover SPRAVATO, and KWC provides assistance with patient coverage options and costs.

Delic Holdings Corp (DELIC, OTCQB: DELCF) announced on May 30, 2022, the filing of its annual financial statements and related documents for the year ended December 31, 2021. This follows a management cease trade order (MCTO) issued on May 3, 2022, which is expected to be revoked shortly. While the MCTO remains, the trading of the company’s securities continues for the general public, but the Company’s CEO and CFO are restricted from trading.

Matt Stang, CEO of Delic Corp, will present the Company's strategic targets at the H.C. Wainwright Annual Global Life Sciences Conference from May 23-26, 2022, in Miami, Florida. Delic, a leader in modern medicines, operates the largest chain of psychedelic wellness clinics in the U.S., focusing on improving access to health benefits through innovative treatments. Stang's presentation will outline the Company's expansion strategy and will be available online starting June 10 at 7 a.m. EST for those unable to attend the conference.

Delic Holdings Corp (CSE: DELC, OTCQB: DELCF) announced a default status report related to its delayed annual financial statements for the fiscal year ending December 31, 2021. The annual filings, initially due on May 2, 2022, are now expected by May 30, 2022. As a result of this delay, a management cease trade order (MCTO) was imposed on May 3, 2022, restricting trading by the CEO and CFO. Delic confirmed no material changes since the last announcement and is committed to fulfilling the information guidelines under NP 12-203 while the delay persists.

Delic Holdings Corp announced a partnership with the Veterans Administration (VA) to cover out-of-pocket costs for veterans in Arizona experiencing treatment-resistant depression, PTSD, and anxiety. Through this initiative, veterans can access ketamine therapy at Ketamine Wellness Centers (KWC) clinics in Phoenix, Tucson, and Mesa-Gilbert with prior VA authorization. This expands KWC's existing partnership with the VA and aims to alleviate challenges veterans face in accessing mental health care. The initiative aligns with KWC's commitment to providing therapeutic services to veterans nationwide.

Ketamine Wellness Centers (KWC) has announced the introduction of NAD+ infusion therapy at six locations starting May 9, 2022. This therapy, aimed at enhancing energy, immunity, and mental health recovery, will be available in clinics located in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas, and Tucson. KWC emphasizes that these treatments will be administered under strict clinical supervision, ensuring high-quality care. The company, the largest ketamine therapy provider in the U.S., aims to expand its services nationwide, continuing to support patients across nine states.

Delic Holdings Corp (DELIC) announced that its annual financial statements for the fiscal year ended December 31, 2021, won't be finalized by the required deadline of May 2, 2022, due to audit delays. This delay is attributed to complexities in valuing a recent acquisition and enhanced auditing processes. Consequently, Delic has applied for a management cease trade order (MCTO) from the British Columbia Securities Commission, effective immediately. The company plans to file its annual filings by May 15, 2022, while complying with alternative information guidelines during this period.

Delic Corp's CEO, Matt Stang, will present the company’s strategic plans at the Planet MicroCap Showcase on May 4, 2022, in Las Vegas, Nevada. Delic, a leader in psychedelic wellness, aims to improve health access through innovative treatments. The event will showcase the company’s development and outlook for the second half of the year, aligning with Delic's mission of reframing the conversation around psychedelics.